InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Stein Robert Benjamin, Directeur Exécutif. Officer active across 1 companies, notably Mimedx Group, INC.. Cumulatively, 5 filings have been logged. Total volume traded: €289k. The latest transaction was disclosed on 28 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations5 total
€48,14214,600 shares@ €3.29740.0048% mcap4.6% of flow
Common Stock
SEC:0001376339-22-000095:0·
€759,328178,571 shares@ €4.25220.076% mcap72.5% of flow
Common Stock
SEC:0001376339-22-000038:0·
€52,19811,672 shares@ €4.4720.0052% mcap5.0% of flow
Common Stock
SEC:0001376339-22-000021:0·
€94,2019,362 shares@ €10.0620.0094% mcap100.0% of flow
Common Stock
SEC:0001376339-21-000097·
€94,2019,362 shares@ €10.0620.0094% mcap9.0% of flow
Common Stock
SEC:0001376339-21-000097:0·
5 of 5 declarations
About Stein Robert Benjamin
Robert Benjamin Stein is the EVP of Research and Development and President of Regenerative Medicine at MiMedx Group, Inc. He is responsible for research and development initiatives focused on innovation in the medical field. Robert plays a key role in the strategy for developing new products and improving existing treatments.
